Issues Archive

The most complete archive of clinical and pathology lab industry news available, including issues from 1997 to the present.

Volume XXVII No. 6 – April 20, 2020

In this issue:

COVID-19 NEWS IS HITTING the laboratory industry hard. With specimens — and therefore revenues — in a deep dive, lab finances are crashing, and COVID-19 testing isn’t entirely making up for the losses. But THE DARK REPORT shows labs how and where to apply for financial aid under federal relief packages. Meanwhile, a pre-eminent pathologist takes readers deep inside the Italian pandemic in an exclusive interview.

View Issue TOC



Volume XXVII No. 5 – March 30, 2020

In this issue:

AS THE CORONAVIRUS PANDEMIC roars through the United States, THE DARK REPORT delivers an unprecedented look from the front lines of the medical battlefield. The lab at the “epicenter of the epicenter” of the American epidemic shares its strategies and lessons learned exclusively with TDR, and the editorial team interviewed several leading pathologists who are battling the disease around the world.

View Issue TOC



Volume XXVII No. 4 – March 9, 2020

In this issue:

CORONAVIRUS HITS THE LAB INDUSTRY especially hard, and THE DARK REPORT is behind the scenes to document early successes. These include the rapid validation of virus tests and the adaption of a mobile phlebotomy lab program to COVID-19 testing by one lab in the heart of the New York pandemic. In non-COVID-19 news, some commercial payers and state Medicaid programs are not paying for new proprietary laboratory analyses (PLA) codes and multianalyte assays with algorithmic analyses (MAAA) codes.

View Issue TOC



Volume XXVII No. 3 – February 17, 2020

In this issue:

IT’S A TALE OF TWO LABS: One saw the handwriting on the wall and took steps to successfully stay in business by producing value-added outcomes. The other was forced to sell its outreach business to Quest Diagnostics. THE DARK REPORT outlines how each lab responded to pressures on their business to stay afloat. Also included in this issue are the details of how a manager of an opioid treatment center in Kentucky pleaded guilty recently to three counts under EKRA: soliciting a bribe, making a false statement, and attempting to tamper with evidence.

View Issue TOC



Volume XXVII No. 2 – January 27, 2020

In this issue:

THE DARK REPORT EXAMINES how using cheap offshore billing companies might come back to bite clinical labs, which are turning to these companies to cut costs in an increasingly stressful business climate. Also in this issue is an insider look at how 33 industry groups came together to help get the Laboratory Access for Beneficiaries (LAB) Act passed, which will relieve some of the most onerous burdens imposed by Protecting Access to Medicare Act of 2016.

View Issue TOC



Volume XXVII No. 1 – January 6, 2020

In this issue:

WILL CLINICAL LABS BE EXCLUDED from the new proposed safe harbors under the Stark Act and the AKS? THE DARK REPORT analyzes the problem and also the warning that lies within CMS’ plans for revisions to the anti-fraud laws. Also in this issue are key health system strategies and lab objectives from inside the highly successful switch to value-based medicine at one hospital lab, which was once considered a candidate for sale.

View Issue TOC



Volume XXVI No. 17 – December 16, 2019

In this issue:

THE MOST IMPORTANT STORY OF THE YEAR is actually 10 stories. THE DARK REPORT delivers a must-read overview of a turbulent 2019 that delivered mostly bad news, but also some opportunities for those with nimble management feet. Also, in Part 2 of our report on lawsuits filed in federal court against the two national labs, an insider-turned-whistleblower makes revealing allegations about the internal policies governing charging high prices to the uninsured patient.

View Issue TOC



Volume XXVI No. 16 – November 25, 2019

In this issue:

UNDERREPORTED BUT CRITICAL TRENDS dominate this issue of THE DARK REPORT. In one, the evidence shows that ICD-10 codes’ richer data are now giving payers brand new opportunities to reject lab payment claims or even try to claw back payments already made. Also, lawsuits alleging that the Blood Brothers are overcharging uninsured patients might actually be an opportunity for labs to be more competitive with the big national labs.

View Issue TOC



Volume XXVI No. 15 – November 4, 2019

In this issue:

THE DARK REPORT DETAILS THE NEW CMS RULE targeting Medicare fraudsters that could entrap clinical labs and pathology groups. At the same time, attorneys outline ways for labs to navigate this new minefield and avoid problems. Also, an expert details six different ways that labs can use their valuable data — without selling it — to improve patient care and lower healthcare costs, with new revenue streams as a bonus.

View Issue TOC



Volume XXVI No. 14 – October 14, 2019

In this issue:

ALL LABORATORIANS must take heed of the disruptive new trends in the healthcare industry, which will affect the way patients, doctors, labs, payers and others interact with each other. Also, THE DARK REPORT explains how a genetic testing fraud, recently the target of federal prosecutors, was executed by the alleged perpetrators.

View Issue TOC



Don’t Be at the Mercy of the Tumultuous Healthcare Revolution

Subscribe to The Dark Report for as little as $15.27 per week.

platinum_edition

Get the most expert business intelligence for clinical laboratories and pathology groups available today. Subscribe to The Dark Report.

How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.